Exo Lab Italia
PrivateLast Round
Series A
Feb 18, 2025
Total Funding Raised
$6.26M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Exo Lab Italia operates in Healthcare & Life Sciences and is based in L'Aquila. Its latest recorded funding round was a Series A round in February 2025.
Exo Lab Italia is a biotechnology company that creates innovative products based on plant exosomes from organic farming for dermocosmetic, nutraceutical, and life science applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exo Lab Italia Comparables
Compare Exo Lab Italia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Active Botanicals Research srl | 81% | |
| Solabia Group | 78% | |
| TIME TRAVELER Inc. | 77% |
For institutional investors. Book with your work email.
Exo Lab Italia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 18, 2025 | ||||
| Accelerator | Oct 1, 2022 | ||||
| Seed | Dec 23, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Exo Lab Italia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Terra Next Accelerator | Accelerator |
| Maia Ventures | Series A |
| CDP Venture Capital SGR | Series A |
| Scientifica Venture Capital | Series A, Accelerator, Seed |
| Riello Investimenti SGR | Series A |
| DSM-Firmenich Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Grew 17% QoQ, from 18 to 21 employees.
- Feb 22, 2026
Grew 31% QoQ from 13 to 17 employees.
For institutional investors. Book with your work email.
Exo Lab Italia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Exo Lab Italia's valuation, stock price, and market status.
Is Exo Lab Italia a public or private company?
Exo Lab Italia is a private company.
What is the current stock price of Exo Lab Italia?
Exo Lab Italia is a private company, so its shares have no public market price. Caplight tracks Exo Lab Italia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Exo Lab Italia worth (valuation)?
Valuation information for Exo Lab Italia is not publicly available.
Can I buy Exo Lab Italia stock?
Exo Lab Italia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Exo Lab Italia's last funding round?
Exo Lab Italia's most recent funding round was Series A on February 18, 2025.
Who are the main investors in Exo Lab Italia?
Key investors in Exo Lab Italia include Terra Next Accelerator, CDP Venture Capital SGR, Scientifica Venture Capital, DSM-Firmenich Ventures.
Will Exo Lab Italia IPO soon?
No public IPO plans have been announced for Exo Lab Italia.
How can I track Exo Lab Italia secondary market activity?
Caplight tracks bids, offers, and trades in Exo Lab Italia's shares on secondary markets.